title: Hypoxia, leptin, and vascular endothelial growth factor stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells.
abstract: The plasticity of human adipose tissue-derived stem cells (hASCs) is promising, but differentiation in vitro toward endothelial cells is poorly understood. Flow cytometry demonstrated that hASCs isolated from excised fat tissue were positive for CD29, CD44, CD70, CD90, CD105, and CD166 and negative for the endothelial marker CD31, and the hematopoietic cell markers CD34 and CD133. hASCs differentiated into adipocytes after cultivation in adipogenic medium. Exposure of hASCs for 10 days under hypoxia (3% oxygen) in combination with leptin increased the percentage of CD31(+) endothelial cells as well as CD31, VE-Cadherin, Flk-1, Tie2, von Willebrand factor, and endothelial cell nitric oxide synthase mRNA expression. This was enhanced on co-incubation of vascular endothelial growth factor (VEGF) and leptin, whereas VEGF alone was not sufficient. Moreover, hASCs cultured on a matrigel surface under hypoxia/VEGF/leptin, showed a stable branching network. Hypoxic conditions significantly decreased apoptosis as evaluated by cleaved caspase-3, and increased prolyl hydroxylase domain 3 mRNA expression. Hypoxia increased expression of VEGF as well as leptin transcripts, which were significantly inhibited on co-incubation with either VEGF or leptin or a combination of both. Furthermore, leptin treatment of hypoxic cells increased the expression of the long/signaling form of the leptin receptor (ObRL), which was augmented on co-incubation with VEGF. The observed endothelial differentiation was dependent on the Akt pathway, as co-administration with Akt inhibitor abolished the observed effects. In conclusion, our data demonstrate that hASCs can be efficiently differentiated to endothelial cells by mimicking the hypoxic and pro-angiogenic microenvironment of adipose tissue.
authors.affiliation: 1 Clinic of Internal Medicine I, Department of Cardiology, University Heart Center, Jena University Hospital , Jena, Germany .
authors.forename: Mohamed M
authors.initials: MM
authors.lastname: Bekhite
authors.forename: Andreas
authors.initials: A
authors.lastname: Finkensieper
authors.forename: Jennifer
authors.initials: J
authors.lastname: Rebhan
authors.forename: Stephanie
authors.initials: S
authors.lastname: Huse
authors.forename: Stefan
authors.initials: S
authors.lastname: Schultze-Mosgau
authors.forename: Hans-Reiner
authors.initials: HR
authors.lastname: Figulla
authors.forename: Heinrich
authors.initials: H
authors.lastname: Sauer
authors.forename: Maria
authors.initials: M
authors.lastname: Wartenberg
mesh_terms: D050153:Abdominal Fat / Q000166:cytology; D053687:Adult Stem Cells / Q000502:physiology*; D000368:Aged; D017209:Apoptosis; D015415:Biomarkers / Q000378:metabolism; D002454:Cell Differentiation; D015687:Cell Hypoxia; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology*; D006801:Humans; D020738:Leptin / Q000502:physiology*; D008875:Middle Aged; D018919:Neovascularization, Physiologic; D059467:Transcriptome; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology*
chemical_list: D015415:Biomarkers; D020738:Leptin; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A